SCHEMBL2642334

SCHEMBL2642334

COc1ccc2nc([NH])sc2n1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 7/20 0.35
PDE2A O00408 3/20 0.35
PDE5A O76074 2/20 0.35
PDE4A P27815 2/20 0.35
PDE7A Q13946 2/20 0.35
PDE3A Q14432 2/20 0.35
PDE11A Q9HCR9 2/20 0.35
PIK3CG P48736 2/20 0.34
PIK3CD O00329 1/20 0.34
PIP5K1C O60331 1/20 0.34
PIK3CA P42336 1/20 0.34
PIK3CB P42338 1/20 0.34
PI4KA P42356 1/20 0.34
PI4KB Q9UBF8 1/20 0.34
POLB P06746 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
GCK P35557 1/20 0.32
ABL1 P00519 1/20 0.32
KMT2A Q03164 2/20 0.32
MEN1 O00255 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30189846 0.79 PDE10A (0.36) PDE10APDE2APDE5APDE4APDE7A
SCHEMBL10049899 0.79 PDE10A (0.44) PDE10APDE2APDE5APDE4APDE7A
SCHEMBL794336 0.79 PDE10A (0.36) PDE10APDE2APDE5APDE4APDE7A
SCHEMBL184747 0.78 PIK3CD (0.50) PDE10APDE2APIK3CGPIK3CDPIP5K1C
SCHEMBL1851332 0.78 PDE10A (0.35) PDE10APDE2APDE5APDE4APDE7A
SCHEMBL30189832 0.78 PIK3CD (0.50) PDE10APDE2APIK3CGPIK3CDPIP5K1C
SCHEMBL4822039 0.77 PDE10A (0.33) PDE10APDE2APDE5APDE4APDE7A
SCHEMBL14243031 0.75 LCK (0.41) PDE10APDE2APDE5APDE4APDE7A
SCHEMBL14243038 0.75 HTT (0.42) PDE10APDE2APDE5APDE4APDE7A
SCHEMBL10271439 0.75 NPC1 (0.43) PDE10APDE2APDE5APDE4APDE7A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7687502-B2 Substituted quinazoline or pyridopyrimidine derivative BANYU PHARMACEUTICAL CO., LTD. (JP) 2010-03-30 US disclosed
US-20080032996-A1 Substituted Quinazoline or Pyridopyrimidine Derivative MSD K.K. (JP) 2008-02-07 US disclosed
EP-1734040-A1 SUBSTITUTED QUINAZOLINE OR PYRIDOPYRIMIDINE DERIVATIVE BANYU PHARMACEUTICAL CO., LTD. (JP) 2006-12-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080032996-A1 Substituted Quinazoline or Pyridopyrimidine Derivative GCK, GCKR, PDXK PDE10A 1938/4885PDE2A 770/4885PDE5A 667/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.